A retrospective study of head and neck re-irradiation for patients with recurrent or second primary head and neck cancer: The McGill University experience

Abstract

Continuous course re-irradiation in patients with LRR or SP head and neck cancer is feasible with acceptable toxicity. With current encouraging rates of local control and overall survival, this option should be discussed with patients who have few alternative therapeutic options.